Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedWellAIMWAI 1 Revenue per Share is $0.23 as of Mar. 2026. GuruFocus rates MWAI with a GF Score™ of 1/100. The stock has 4 warning signs investors should review. Among 714 Capital Markets companies, MedWellAI ranks worse than 97.76% on this metric.
MedWellAI's revenue per share for the
three
months ended in Mar. 2026 was $0.10.
MedWellAI's revenue per share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.23.
Warning Sign:
MedWellAI Inc revenue per share has been in decline over the past 3 years.
During the past 3 years, the average Revenue Per Share Growth Rate was -70.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for MedWellAI's Revenue per Share or its related term are showing as below:
MWAI'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -70.4 Med: -7.05 Max: 25.6
Current: -70.4
During the past 13 years, MedWellAI's highest 3-Year average Revenue Per Share Growth Rate was 25.60% per year. The lowest was -70.40% per year. And the median was -7.05% per year.
MWAI's 3-Year Revenue Growth Rate is ranked worse than 97.76% of 714
companies
in the Capital Markets industry
Industry Median: 8.2
vs MWAI: -70.40
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
MedWellAI Revenue per Share Related Terms
MedWellAI Revenue per Share Historical Data
* Premium members only.
The historical data trend for MedWellAI's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MWAI vs PMAX, PWCM, IPST: Revenue per Share Comparison
For the Capital Markets subindustry, MedWellAI's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedWellAI PS Ratio vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, MedWellAI's PS Ratio distribution charts can be found below:
* The bar in red indicates where MedWellAI's PS Ratio falls into.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
MedWellAI's Revenue Per Share for the fiscal year that ended in Jun. 2025 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.23
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedWellAI (MWAI) has a Revenue per Share of $0.23 as of Mar. 2026. Revenue per share equals the per-share value of a company's sales. View historical data on MedWellAI and its competitors. According to the industry distribution chart, MedWellAI ranks #698 out of 714 companies in the Capital Markets industry, placing it in the top 97.8%.
Is MedWellAI's Revenue per Share too high?
MedWellAI's current Revenue per Share is $0.23. The Capital Markets industry median Revenue per Share is 8.20. MedWellAI's value of $0.23 is 97.2% below this industry median. Based on the distribution chart, MedWellAI ranks #698 out of 714 companies in the Capital Markets industry, which is in the bottom quartile relative to peers. Overall, MedWellAI has a GF Score™ of 1/100, reflecting its overall financial health beyond just this single metric.
How does MedWellAI's Revenue per Share compare to PMAX and PWCM?
According to the Capital Markets industry distribution chart, MedWellAI ranks #698 out of 714 companies for Revenue per Share. This places MedWellAI in the lower half of its industry. The industry median Revenue per Share is 8.20. MedWellAI's value of $0.23 is 97.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue per Share for a Capital Markets company?
The median Revenue per Share among Capital Markets companies is 8.20, based on 714 companies in the industry. Companies in the top quartile (top 25%) have a Revenue per Share significantly above this median, while those in the bottom quartile fall well below. However, Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MedWellAI's current Revenue per Share of $0.23 is 97.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue per Share mean?
A high Revenue per Share can signal that a stock is expensive relative to its fundamentals. Revenue per share equals the per-share value of a company's sales. View historical data on MedWellAI and its competitors. For the Capital Markets industry, the median Revenue per Share is 8.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedWellAI's current Revenue per Share is $0.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedWellAI stock overvalued right now?
MedWellAI (MWAI) has a current Revenue per Share of $0.23. The current Revenue per Share is $0.23 and 97.2% below the Capital Markets industry median of 8.20. MedWellAI's overall GF Score™ is 1/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue per Share calculated?
Revenue per Share is calculated from a company's financial statements. For MedWellAI (MWAI), the current Revenue per Share is $0.23 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MedWellAI Inc is a holding company focused on AI-driven healthcare and wellness solutions, offering a B2B platform for GLP medications with real-time inventory and provider support. The company operates as a single operating segment, focusing on acquiring, launching, and operating companies in the rapidly growing health and wellness sector.
1GF Score
Get the complete analysis for MWAI
Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MWAI has been successfully added to your 
